Higher surgical risks of open repair for inflammatory abdominal aortic aneurysm (I-AAA) associated with severe adhesion around the aneurysm have been reported. Recently endovascular aneurysm repair (EVAR) for I-AAA has been advocated. We experienced an I-AAA with increased fluorine-18 fluoro-deoxyglucose (18 F-FDG) uptake in the aneurysm wall, which was revealed by positron emission tomography/ computer tomography (PET-CT), and disappeared 6 months after EVAR. The mechanism, by which inflammation of the aneurysm wall was improved, could not be specified, but a reduction of the pressure load on the aneurysm wall by EVAR may have played a role.
A 54-year-old man with unstable angina and Wolff-Parkinson-White (WPW) syndrome was admitted.Coronary angiography showed 90% stenosis of the left main trunk and 75% stenosis of the obtuse marginal branch. Coronary artery bypass grafting under cardioplegic arrest was done emergently.The left internal mammary artery graft was anastmosed to the left anterior descending artery, and a saphenous vein graft was used as a sequential bypass graft to the high lateral branch and obtuse marginal branch. Immediately after weaning from cardiopulmonary bypass, paroxysmal supraventricular tachycardia (PSVT) requiring electrical cardioversion was occurred, and catheter ablation was performed on the first postoperative day. There are controversus concerning the strategies of surgical treatment for unstable angina concomitant with WPW syndrome.Coronary bypass operation may trigger PSVT in patients with WPW syndrome. The optimal timing of perioperative catheter ablation needs further discussion.Jpn.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.